RESULTS	Patients on TNF spent a mean 26 weeks ( 95 % CI 18 to 34 ) with inactive disease , longer than did those receiving COMBO ( 13 weeks ; 95 % CI 6 to 20 ) , or methotrexate ( 6 weeks ; 95 % CI 2 to 10 ) .\